Trial Profile

The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
Indications Allergic rhinoconjunctivitis
Focus Therapeutic Use

Most Recent Events

15 Feb 2018 New trial record
09 Feb 2018 Primary endpoint (Change in Total Nasal Symptom Score (TNSS) From Baseline to Post-treatment.) has not been met as per the results published in the Annals of Allergy, Asthma and Immunology
09 Feb 2018 Results published in the Annals of Allergy, Asthma and Immunology

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com